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Background: One of the most attractive properties of quantum dots is their potential to extend 
the opportunities for fluorescent and multimodal imaging in vivo. The aim of the present study 
was to clarify whether the composition and structure of organic coating of nanoparticles are 
crucial for their application in vivo.
Methods: We compared quantum dots coated with non-crosslinked   amino-functionalized polyami-
doamine (PAMAM) dendrimers, quantum dots encapsulated in crosslinked   carboxyl-functionalized 
PAMAM dendrimers, and silica-shelled amino-functionalized quantum dots. A multimodal 
fluorescent and paramagnetic quantum dot probe was also developed and analyzed. The probes 
were applied intravenously in anesthetized animals for visualization of brain vasculature using 
two-photon excited fluorescent microscopy and visualization of tumors using fluorescent IVIS® 
imaging (Caliper Life Sciences, Hopkinton, MA) and magnetic resonance imaging.
Results: Quantum dots coated with non-crosslinked dendrimers were cytotoxic. They induced side 
effects in vivo, including vasodilatation with a decrease in mean arterial blood pressure and heart 
rate. The quantum dots penetrated the vessels, which caused the quality of fluorescent imaging to 
deteriorate. Quantum dots encapsulated in crosslinked dendrimers had low cytotoxicity and were 
biocompatible. In concentrations 0.3 nmol quantum dots/kg bodyweight, these nanoparticles 
did not affect blood pressure and heart rate, and did not induce vasodilatation or vasoconstric-
tion. PEGylation (PEG [polyethylene glycol]) was an indispensable step in development of a 
quantum dot probe for in vivo imaging, based on silica-shelled quantum dots. The non-PEGylated 
silica-shelled quantum dots possessed low colloidal stability in high-salt physiological fluids, 
accompanied by rapid aggregation in vivo. The conjugation of silica-shelled quantum dots with 
PEG1100 increased their stability and half-life in the circulation without significant enhancement 
of their size. In concentrations 2.5 nmol/kg bodyweight, these quantum dots did not affect the 
main physiological variables. It was possible to visualize capillaries, which makes this quantum 
dot probe appropriate for investigation of mediators of vasoconstriction, vasodilatation, and brain 
circulation in intact animals in vivo. The multimodal silica-shelled quantum dots allowed visual-
ization of tumor tissue in an early stage of its development, using magnetic resonance imaging.
Conclusion: The present study shows that the type and structure of organic/bioorganic shells of 
quantum dots determine their biocompatibility and are crucial for their application in imaging 
in vivo, due to the effects of the shell on the following properties: colloidal stability, solubility 
in physiological fluids, influence of the basic physiological parameters, and cytotoxicity.
Keywords: quantum dot, organic shell, biocompatibility, in vivo imaging, two-photon excited 
fluorescent microscopy, magnetic resonance imaging
Introduction
One of the most attractive properties of quantum dots is their potential to extend the 
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(over 50%) and large excitation/emission Stokes shift (up 
to 300 nm) allow minimization of tissue autofluorescence, 
especially when using quantum dots with deep-red or near-
infrared emission. The high intensity of multiphoton excited 
fluorescence of quantum dots and the possibility for time-
resolved detection of fluorescence additionally increase the 
signal-to-background ratio in the living organism. Using 
quantum dots it is possible to visualize complex structures, 
cells, and even molecular targets at significantly greater depth 
in vivo, in comparison with that achieved by conventional 
organic fluorophores.1–3 The chemically functionalized 
surface of quantum dots, encapsulated in silica or other 
organic/bioorganic shells, also opens up an opportunity for 
development of multimodal probes, applicable in two or more 
imaging techniques, eg, magnetic resonance imaging/optical, 
positron emission tomography/optical, and positron emission 
tomography/magnetic resonance imaging/optical).1–4
In the development of quantum dot probes for in vivo 
multimodal imaging, it is necessary to follow a few rules.4 
The most important are that the quantum dot nanocrystal 
has to be encapsulated in a bioinert and biocompatible shell 
to isolate it from the environment and to minimize its tox-
icity, and that the capsulated quantum dot nanocrystal has 
to be conjugated with biocompatible substances (usually 
polymers), decreasing its rate of accumulation in the liver 
and spleen and increasing the half-life in the bloodstream, 
facilitating access of quantum dots to the respective target and 
its visualization, and preventing opsonization and induction 
of a nonspecific immune response.5 The bioinert polymer 
shells may also increase the water solubility of quantum dots, 
which facilitates their excretion from the organism through 
renal filtration and decreases their toxicity.6,7
The idea of encapsulation of nanoparticles in biocompat-
ible shells and their conjugation with biocompatible polymers 
emerged in the mid 1990s in the context of development of 
water-soluble paramagnetic and ferromagnetic nanoparticles 
for bioanalyses,8,9 as a result of earlier experience in the syn-
thesis of biocompatible polymers for drug encapsulation and 
delivery.10–12 The earliest and most frequently used polymers 
for encapsulation of nanoparticles are polyethylene glycol 
(PEG) and dextran, as well as silica/silicagel shells.8,9 Later, 
biocompatible dendrimers and diblock/triblock copolymers 
were included in the composition.13,14
Dextran and PEG make the nanoparticles hydrophilic and 
increase their half-life in the circulation. However, in some 
cases, the dextran can induce an acute immune response as 
anaphylaxis.15 Currently, PEG or PEG derivatives are the 
polymers most commonly used to stabilize nanoparticles 
and to extend their half-life in the bloodstream due to the 
“sterically stabilizing effect of PEG”.16 PEG forms a protec-
tive hydrophilic layer on the surface, preventing interaction 
between blood lipoproteins and cells (eg, macrophages) and 
significantly delays accumulation of the nanoparticles in the 
liver and spleen.5 This is an essential condition for develop-
ment of contrast nanoprobes for imaging diagnostics, because 
it enables a longer scan time and accurate localization and 
visualization of the target of interest (tissues, cells, or expres-
sion of specific receptors or molecules). Therefore, PEGyla-
tion seems to be an indispensable step in the development 
of quantum dot probes for in vivo diagnostic imaging. The 
longer half-life of PEGylated quantum dots in the circula-
tion also contributes to their effectiveness in target-specific 
diagnostic imaging. Penetration of quantum dots into the vas-
culature and their localization in target tissue is known as the 
“enhanced permeability and retention effect.” There are also 
other polymers, including poly(oxazoline), poly(glycerol), 
and poly-N-vinylpyrrolidone, which have a sterically stabi-
lizing action on nanoparticles.17,18
In the present study, we demonstrate the importance of 
the chemical nature and structure of the organic/bioorganic 
shells of quantum dots for their application in in vivo diag-
nostic imaging. Several quantum dot probes were developed 
and their biocompatibility was investigated and compared in 
experimental animals, using conventional physiological tests 
and two-photon excited fluorescent microscopy.
Materials and methods
Quantum dots and quantum dot probes
CdSe/ZnS quantum dots were synthesized using the methods 
described by Peng and Peng19 and Zlateva et al.20 Nanocrystals 
were characterized by ultraviolet light/ultraviolet and fluo-
rescent spectroscopy, X-ray analysis (Rigaku RINT-2100, 
Tokyo, Japan), and high-resolution transmission electron 
microscopy (JEOL JEM-3010, Tokyo, Japan).
The concentration of quantum dots was calculated 
using the method of Yu et al, with an extinction coefficient 
of 1 × 105/cm/M.21 Quantum dots were additionally coated 
with silica as described by Bakalova et al,22 polyamidoamine 
(PAMAM) dendrimers as described by Wu et al23 (with a slight 
modification of using the second-generation PAMAM-C12 
dendrimer [Sigma-Aldrich, St Louis, MO] instead of octylamine-
modified polyacrylic acid), and the second-generation 
PAMAM-C12 dendrimer (Sigma-Aldrich) crosslinked by 
a PAMAM-succinamic acid dendrimer (Sigma-Aldrich), 
with N-(3-dimethylaminopropyl)-N′-ethyl-carbodiimide 
hydrochloride used as a zero-length crosslinker.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The conjugation of silica- or dendrimer-coated quantum 
dots with PEG was carried out using the method described 
in Hermanson.24 Methyl-PEGn-NHS esters or methyl-PEGn 
amines were used for conjugation with amino-functionalized 
or carboxy-functionalized quantum dots, respectively. The 
coated quantum dots and quantum dot-PEG conjugates 
were purified by spin ultrafiltration and kept at 4°C. The 
amino-functionalized silica-shelled quantum dots were also 
conjugated with DOTA-phenyl isothiocyanate (DOTA-Bn-
NCS/gadolinium, Macrocyclics Company, Dallas, TX) and 
PEGylated using methods described by Hermanson.24 The 
quantum dot/DOTA/PEG conjugates were purified by dialysis 
using a Slide-A-LyzerR (Pierce Biotechnology Inc, Rockford, 
IL). The multimodal quantum dots were kept at 4°C. Their T1 
and T2 contrast properties were characterized using 7 Tesla 
magnetic resonance imaging (Kobelco, Kobe, Japan).25 All 
reagents used in this study were of analytical or high-pressure 
liquid chromatographic grade.
Animals and experimental models
Sprague-Dawley rats weighing 325 ± 15 g were used for 
investigation of the biocompatibility of the quantum dot 
probes and their usefulness for fluorescent imaging in vivo. 
Balb6 nude mice (22 ± g) were used for investigation of the 
usefulness of quantum dot probes for multimodal imaging 
of experimental tumors in vivo. Colon26 cells (1 × 105 in 
10 µL phosphate-buffered saline, pH 7.4) were inoculated 
subdermally in the left/right hindpaw. All measurements were 
performed five or ten days after inoculation, when the tumor 
was 1–2 mm or 5–6 mm in size, respectively.
All experiments were conducted in accordance with the 
guidelines of the Physiological Society of Japan and were 
approved by the Animal Care and Use Committee of the 
National Institute of Radiological Sciences, Chiba, Japan.
Two-photon imaging of brain  
circulation in vivo
The rat was anesthetized with isoflurane (Abbott, Tokyo, 
Japan) 4% for induction, 2% for surgery, and 1.4% during 
measurements. Tracheal intubation was performed, and the 
femoral vein was catheterized for drug administration. The 
tail artery was catheterized for blood pressure monitoring 
and blood sampling. The rat was fixed in a stereotactic 
frame, the parietal bone was thinned to translucency over 
the somatosensory cortex (3 mm × 3 mm), and the dura was 
kept intact. Body temperature was maintained at 37°C, and 
systemic arterial blood pressure was periodically monitored 
at the tail artery. Heart rate and end-tidal gas levels were 
monitored continuously. To visualize the brain microcircula-
tion, the quantum dot probe was injected (intravenously as a 
single dose, with an injected volume of 0.3 mL, containing 
different quantum dot concentrations), and the brain area was 
excited by an 810 nm pulse laser (Maitai HP, Spectra-Physics, 
Irvine, CA) under microscope (SP5, Leica) equipped with 
a 10× objective lens (0.30 numerical aperture). The vessel 
diameter was then determined by measuring the width of 
the vessel image projected across the 15 Z images (up to 
nearly 0.3 mm from the cortical surface) in each vessel 
  segment. The experimental scheme is shown in Supplemen-
tary Figure S1.
IVIs® imaging in vivo
The mouse was anesthetized with 1.5% isoflurane (Abbott). 
The tail veil was catheterized for drug administration and the 
mouse was fixed in the camera of the IVIS® imaging system 
(Caliper Life Sciences, Hopkinton, MA). Body autofluores-
cence was registered using an excitation filter of 450 ± 30 nm 
and an emission filter of 650 nm. The quantum dot probe 
was injected (intravenously as a single dose of 1.6 nmol/
kg bodyweight, 100 µL volume) and body fluorescence 
was registered at a series of time intervals over 90 minutes. 
The data were analyzed by Living ImageR software (version 
2.50.1, Xenogen Corporation, Alameda, CA).
Magnetic resonance imaging in vivo
Magnetic resonance imaging measurements were performed 
on a 7.0 Tesla horizontal magnet (Kobelco and Jastec, Tokyo, 
Japan) interfaced to a Bruker Avance I console (Bruker 
BioSpin, Karlsruhe, Germany) and controlled with ParaVision 
4.0.1 (Bruker BioSpin). The animal (a Balb6 mouse) was 
anesthetized using isoflurane 1.5% and held in a body 
cradle (Rapid Biomedical, Rimpar, Germany) in the prone 
position. Rectal temperature was continuously monitored and 
automatically controlled at 36.5 ± 0.5°C using a nonmagnetic 
temperature probe (FOT-M and FTI-10, FISO Technology, 
Olching, Germany) and an electric temperature controller 
(E5CN, Omron, Kyoto, Japan) during magnetic resonance 
imaging measurements. The tail vein was catheterized using a 
polyethylene tube (PE-10, Becton-Dickinson, Franklin Lakes, 
NJ) for drug administration. The mouse was then placed in 
a proton volume radiofrequency resonator (Bruker BioSpin) 
with a surface radiofrequency receiver (Rapid Biomedical) 
previously warmed using a body temperature controller 
(Rapid Biomedical). The resonator units, including the mouse, 
were placed in the magnet bore. Magnetic resonance imaging 
was performed using the following parameters: T1-weighted International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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imaging; spin echo sequence with fat suppression preparation 
pulse; repetition time 400 msec; echo time 9.574 msec; field 
of view 32 × 32 mm; matrix size 256 × 256; slice thickness 
1.0 mm; spatial resolution 125 × 125 × 1000 µm; four aver-
ages; and a total scan time of six minutes and 50 seconds. 
The magnetic resonance images were obtained before and 
after injection of the quantum dot probe (intravenously, single 
dose of 1 µmol/kg bodyweight, 100 µL volume) using the 
same gain level. The magnetic resonance imaging data were 
reconstructed by ParaVision and analyzed using MRVision 
image analysis software (version 1.5.8, MRVision Co, Win-
chester, MA).
Flow-cytometric cell viability assay
The cell suspension (5 × 105 cells/mL) was incubated with 
quantum dots at a series of concentrations over 24 hours 
in a humidified atmosphere and washed three times with 
phosphate-buffered saline. Five hundred microliters of the 
same cell suspension was incubated with 20 µL of propidium 
iodide (Sigma-Aldrich) for 10 minutes at room temperature. 
The cells were washed three times by phosphate-buffered 
saline, using centrifugation (1000 × g/10 minutes), and 
finally resuspended in 500 µL of phosphate-buffered saline. 
The propidium iodide entered the dead cells and did not 
enter the live ones. The cell suspension was subjected to flow 
cytometric analysis, using a Beckman Coulter-Epics XL flow 
cytometer (Fullerton, CA), operated in accordance with the 
manufacturer’s recommendations after fine adjustments for 
optimization of the measurements. The forward-scattered 
and side-scattered parameters were adjusted to accommodate 
the inclusion of viable and dead cells within the acquisition 
data. No cells were excluded from the analysis, and about 
10,000 cells were counted. Data were collected and analyzed 
using XL System II software.
The results were presented as a dot plot of cell fluores-
cence with quadrant markers drawn to distinguish viable 
(nonlabeled) and dead (propidium iodide-labeled) cells 
(Figure 1).
Cell viability after treatment with quantum dots was 
calculated by the following equation:
cellviability (%) = 
B
B+  (DD )
  
p
pp c −
× 100
where Bp is the number of viable cells in quadrant B of the 
sample, treated by quantum dots; Dp is the number of dead 
cells in quadrant D of the sample, treated by quantum dots; 
Dc is the number of dead cells in quadrant D of the control 
sample (not treated with quantum dots). Quantum dot485 
probes were used in all flow cytometric analyses.
Mitochondrial potential assay
The mitochondrial potential was analyzed using the method 
described by Wong and Cortopassi26 using 48-well plates 
and tetramethylrhodamine ethyl ester as a fluorescent 
marker (TMRE, Immunochem Diagnostic Technologies 
Ltd, Truro, Nova Scotia). Briefly, 50 nM of TMRE was 
added to 500 µL of cell suspension (1 × 106 cells/mL), and 
the fluorescence was measured using a BioRad microplate 
reader (BioRad Laboratories, Hercules, CA) equipped 
with a temperature controller. The temperature of the cell 
suspension was maintained at 37°C. The fluorescence of 
each well was detected over two cycles every five minutes 
at λex = 540 nm and λem = 575 nm. A quantum dot485 probe 
was added to each well and the fluorescence detection was 
continued over seven cycles every five minutes. The data 
were normalized to the autofluorescence of the quantum 
dot and the cell suspension was not treated with TMRE 
(baseline fluorescence).
Results and discussion
Biocompatibility of dendrimer-shelled 
quantum dots
Two quantum dot probes were developed using PAMAM 
dendrimers as an organic shell (Figure 2). For the first 
probe, a quantum dot nanocrystal was coated with a non-
crosslinked second generation PAMAM C12 dendrimer). 
The carbohydrate chains (C12) of dendrimer interact with 
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Figure 1 A flow cytometric histogram of cell fluorescence with quadrant markers, 
drawn to distinguished viable (nonlabeled) from dead (propidium iodide-labeled) 
cells. Quadrant B shows viable cells and quadrant D shows dead cells.International Journal of Nanomedicine 2011:6
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Figure 2 Model structure of quantum dot probes, consisting of cdse/Zns quantum dots coated with non-crosslinked PAMAM dendrimers or encapsulated in crosslinked 
PAMAM dendrimers.
Abbreviations: PAMAM, polyamidoamine; eDc, 1-ethyl-3(3-dimethylamino propyl)-carbodiimide; QD, quantum dot.
5 min after 20 min after
5 min after 20 min after
A   CdSe/ZnS QD, capsulated in PAMAM
      dendrimers (0.3 nmol/kg bodyweight)
B  CdSe/ZnS QD, capsulated in crosslinked
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Figure 3 Two-photon excited fluorescent images of brain vasculature in horizontal 
planes (at 150 µm depth from brain surface) after intravenous injection of QD525 
(coated with non-crosslinked PAMAM dendrimers [A] or capsulated in crosslinked 
dendrimers [B] in the anesthetized rat).
Notes: All images were obtained at λex = 810 nm and a mean laser power of about 
2.7 W. Detectors: filter/band-pass 525/50 nm (via 560/10 nm beam splitter).
Abbreviations: PAMAM, polyamidoamine; QD, quantum dot.
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the hydrophobic coordinating ligands of the quantum dot via 
van der Waals interactions. As a result, the surface of this 
dendrimer-coated quantum dot was amino-functionalized 
and positively charged. The second quantum dot probe was 
developed from the first one through a crosslink between 
the surface amino groups of the PAMAM C12 dendrimer 
and the carboxyl groups of the second-generation PAMAM 
succinamic acid dendrimer, with formation of amide bonds 
(Figure 2). Thus, in the second quantum dot probe, the 
nanocrystal was capsulated in crosslinked PAMAM den-
drimers, and the surface of the nanoparticles was carboxyl-
functionalized and negatively charged.
The zeta potential of amino-functionalized dendrimer-
coated quantum dots was about +7.0 mV at pH 7.4, and for 
carboxyl-functionalized dendrimer-capsulated quantum dots 
was about −18.7 mV at pH 7.4. Both measurements were made 
in phosphate-buffered saline. Both quantum dot probes were 
characterized with excellent solubility in distilled water, and 
low-salt and high-salt physiological fluids (eg, buffers, saline 
solution, phosphate-buffered saline, cell cultured medium, 
plasma). The quantum dot probes were used for in vivo fluo-
rescent imaging of the brain circulation in anesthetized rats, 
using two-photon excited fluorescent microscopy.
Figure 3 shows two-photon excited fluorescent images 
of brain vasculature after intravenous injection of den-
drimer-coated quantum dots525. The images were obtained 
at λex = 810 nm with an emission filter of 525 ± 50 nm, in 
a horizontal scanning plane at a depth of 150 µm from the 
surface of the skull.
In the case of quantum dots coated with non-crosslinked 
dendrimers, turbidity of the images increased during the 
scan time (Figure 3A). This impeded measurement and 
calculation of the average diameter of the arterioles and 
venuoles.   Concentration of the injected quantum dot probe International Journal of Nanomedicine 2011:6
Table 2   Physiological  characteristics  of  rats  before  and  after 
intravenous  injection  of  QDs  (encapsulated  in  crosslinked 
PAMAM dendrimers)
Parameters Before  
injection
About 20 minutes  
after injection
P value
Mean arterial blood  
pressure (mmhg)
96.8 ± 4.9 100.5 ± 8.4 Ns
heart rate (beats  
per minute)
340 ± 21 336 ± 23 Ns
Mean diameter of  
detected arteries (µm)
23 ± 10 constant Ns
Mean diameter of  
detected veins (µm)
41 ± 20 constant Ns
Notes:  Means  ±  standard  deviations  from  six  independent  experiments.  QD 
concentration 0.3 nmol/kg bodyweight.
Abbreviations: QD, quantum dot; NS, not significant; PAMAM, polyamidoamine.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1724
Bakalova et al
was 0.3 nmol quantum dots/kg bodyweight. Increasing the 
concentration also made it difficult to define the outlines 
of the large blood vessels (arteries and veins). Intravenous 
injection of this quantum dot probe changed the basic physi-
ological characteristics of the animal (Table 1). Mean arterial 
blood pressure and heart rate decreased, accompanied by 
vasodilatation.
PAMAM C12 dendrimers (without quantum dots) had 
similar effects (see Table S1 for supplementary information). 
Even low concentrations of the PAMAM C12 dendrimer 
(0.1 nmol/kg bodyweight injected intravenously in the 
rat) decreased blood pressure and heart rate and induced 
vasodilatation.
In the case of quantum dots encapsulated in crosslinked 
dendrimers, the turbidity of the fluorescent images was negli-
gible (Figure 3B). The images did not change during the scan 
time. The large and small blood vessels were well outlined and 
it was easy to measure their average diameter. This quantum 
dot probe did not affect mean arterial blood pressure or heart 
rate (Table 2) even one hour after injection.
The dendrimer-encapsulated quantum dots were also 
PEGylated using PEG1100. However, PEGylation did not 
significantly increase the half-life of the quantum dots in the 
Table 1   Physiological  characteristics  of  rats  before  and  after 
intravenous  injection  of  QDs  (coated  with  noncrosslinked 
PAMAM dendrimers)
Parameters Before  
injection
About 20 minutes  
after injection
P value
Mean arterial blood  
pressure (mmhg)
102.5 ± 2.5 75.5 ± 7.1 0.05
heart rate  
(beats per minute)
378 ± 29 310 ± 15 0.05
Mean diameter of  
detected arteries (µm)
28 ± 9 35 ± 10  
(vasodilatation)
0.05
Mean diameter of  
detected veins (µm)
42 ± 23 45 ± 18 (slight 
vasodilatation)
Ns
Notes:  Means  ±  standard  deviations  from  six  independent  experiments.  QD 
concentration 0.3 nmol/kg bodyweight.
Abbreviations: QD, quantum dot; NS, not significant; PAMAM, polyamidoamine.
Table 3 effect of cdse/Zns QD485 (coated with noncrosslinked 
PAMAM dendrimers) on cell viability in vitro (% from control)
Cell  
line
10 nM  
QD
50 nM  
QD
100 nM  
QD
200 nM  
QD
500 nM   
QD
Jurkat 99 ± 7 97 ± 5 62 ± 5 30 ± 7 21 ± 4
K562 101 ± 6 98 ± 9 62 ± 9 37 ± 5 16 ± 3
A549 103 ± 9 101 ± 5 65 ± 7 39 ± 5 28 ± 5
heLa 99 ± 3 100 ± 5 60 ± 8 32 ± 3 20 ± 4
Notes: The cell suspension (5 × 105 cells/mL) was incubated with QDs over 24 hours 
in  a  humidified  atmosphere,  and  cell  viability  was  analyzed  by  flow  cytometry. 
cell viability in the absence of QD was considered 100% (control). The data are 
mean ± standard deviation from six independent experiments.
Abbreviations: QD, quantum dot; PAMAM, polyamidoamine.
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brain circulation (elimination half-life was approximately 
65 minutes for the non-PEGylated probe and approximately 
70 minutes for the PEGylated probe), and is not an obligatory 
step for dendrimer-coated quantum dots.
These results demonstrate the importance of the nature 
and structure of the organic shell of quantum dots for 
their application in vivo. The positively charged quan-
tum dot probe, consisting of quantum dots coated with 
non-crosslinked PAMAM dendrimers, caused side effects in 
vivo, accompanied by poor quality of the fluorescent images. 
This quantum dot probe is not appropriate for visualization 
of the brain vasculature and investigation of the biological 
phenomena related to the brain circulation. Turbidity of the 
images after injection of this probe could be explained by 
its transepithelial and transendothelial penetration. Kitchens 
et al27 have reported that the cationic PAMAM dendrimers 
(generation 0–4) are highly permeable for epithelial and 
endothelial cells and penetrate easily and rapidly through the 
blood vessels. This property of PAMAM dendrimers is widely 
used in development of drug delivery systems.28–31 Quantum 
dots coated with noncrosslinked PAMAM dendrimers were 
also cytotoxic (Table 3), and their application for in vitro 
imaging analyses was limited.
PAMAM C12 dendrimers had similar cytotoxic effects 
in vitro, while positively charged water-soluble quantum 
dots, prepared by direct surface exchange of hydrophobic 
coordinating ligands with cysteamine, were noncytotoxic in 
concentrations up to 500 nM and at 24 hours’ incubation time 
(see Tables S2 and S3 for supplementary information). This 
is in agreement with data reported in 2004 by Derfus et al.32 
The authors found that noncoated CdSe/ZnS quantum dots 
were not cytotoxic in concentrations up to 1 µM, even after 
ultraviolet irradiation.
The encapsulation of quantum dots in negatively 
charged crosslinked dendrimers decreased their cyto-
toxicity and abolished the side effects on physiological 
variables in vivo. The encapsulated quantum dots did not 
show cytotoxicity in concentrations up to 500 nM (data 
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Abbreviations: QD, quantum dot; Peg, polyethylene glycol.
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Quantum dot
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Figure 6 electron micrographs of nasal mucosa one day after intranasal inoculation 
of  amino-functionalized  silica-shelled  quantum  dots  (dissolved  in  distilled  water, 
30 drops per animal, single dose).
Abbreviation: QD, quantum dot.
5 min after 20 min after
Figure 7 Two-photon excited fluorescent images of brain vasculature in horizontal 
planes  (at  150  µm  depth  from  the  brain  surface)  after  intravenous  injection  of 
Peg1100-grafted silica-shelled QD525 (2.5 nmol/kg bodyweight) in the anesthetized 
rat. The images were obtained at λex = 810 nm and a mean laser power of about 
2.7 W. Detectors: filter/band-pass: 525/50 nm (via a 560/10 nm beam splitter).
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not shown), whereas the quantum dots coated with non-
crosslinked dendrimers were highly cytotoxic in concen-
trations 50 nM.
The cytotoxicity of quantum dots coated with non-
crosslinked dendrimers can be explained with the intrinsic 
instability of the micelle type of dendrimer coat. The micelle 
structure is a result of weak hydrophobic interactions, and its 
partial destruction in the cell suspension is highly possible. 
Thus, cytotoxic monomers can be released into the intracel-
lular and extracellular environment. Several groups have 
also shown that cationic PAMAM dendrimers are cytotoxic 
in their monomer form.33–38
The micelle type of organic coat could also be destroyed 
in the bloodstream, and the monomers can have side effects 
on blood pressure and heart rate (Table 1 and Table 2). It has 
been established in vitro that the cationic PAMAM dendrimers 
modulate the release of nitric oxide, one of the major vasodila-
tors in vivo,39 while the anionic PAMAM-COOH dendrimers 
significantly reduce this process.36 In our study, we observed 
vasodilatation of the brain arterioles and venuoles after injec-
tion of quantum dots coated by non-crosslinked positively 
charged dendrimers (Table 1). The quantum dots encapsulated 
Table  4  Physiological  characteristics  of  rats  before  and  after 
intravenous injection of Peg1100-grafted silica-shelled QDs
Parameters Before  
injection
About 20 minutes  
after injection
P value
Mean arterial blood  
pressure (mmhg)
96.2 ± 5.4 95.3 ± 12.8 Ns
heart rate  
(beats per minute)
320 ± 55 345 ± 51 Ns
Mean diameter of  
detected arteries (µm)
24 ± 9 constant Ns
Mean diameter of  
detected veins (µm)
41 ± 22 constant Ns
Notes:  Means  ±  standard  deviations  from  six  independent  experiments.  QD 
concentration 0.4 nmol/kg bodyweight. 
Abbreviations: QD, quantum dot; NS, not significant; PEG, polyethylene glycol.
in crosslinked carboxyl-functionalized dendrimers did not 
manifest such effects (Table 2). The encapsulated organic coat 
is stable because of covalent bonds, and release of monomers 
is impossible without a specific metabolic pathway.
It is widely accepted that the cytotoxicity of dendrimers is 
due to their high cellular permeability and colocalization in the 
mitochondria and lysosomes.35,40 We investigated the effect of 
both quantum dot probes on the mitochondrial potential (∆ψm) 
of living cells (Figure 4). The mitochondrial potential is one of 
the major markers for induction of apoptosis. For this purpose, 
we used the quantum dot485 and TMRE (λem = 575 nm) as a 
fluorescent sensor. The fluorescence of TMRE changes propor-
tionate to mitochondrial potential. Loss of the mitochondrial 
potential is accompanied by a significant decrease or total 
loss of TMRE fluorescence.26 The kinetic curves in Figure 4A 
show that quantum dots coated with non-crosslinked PAMAM 
dendrimers induce depolarization of the mitochondrial mem-
brane and loss of the mitochondrial potential in living cells. 
The quantum dots encapsulated in crosslinked dendrimers did 
not affect the mitochondrial potential.
It is widely accepted that loss of mitochondrial potential 
induces expression of cytochrome c and apoptotic peptidase-
activating factor 1. This leads to activation of caspases, 
induction of apoptosis, and cell death.41–43 This molecular 
mechanism could explain, at least partially, the cytotoxic 
effect of quantum dots coated with non-crosslinked PAMAM 
dendrimers (Figure 4B).
Biocompatibility of silica-shelled  
quantum dots
Silica materials are one of the most bioinert and biocom-
patible materials for coating. It has been found that silica 
nanoparticles with diameters below 50 nm do not activate 
macrophages44–46 and should not induce an immune response 
after intravenous injection. However, silica shells do not 
provide sufficiently high solubility of quantum dots in high-
salt physiological fluids, such as saline solution, phosphate-
buffered saline, blood, and plasma.47
In 2006, we developed silica-shelled single CdSe/ZnS 
quantum dots with an average diameter of 17.42 ± 2.12 nm, 
a size distribution of about 12%, and a quantum yield of 
30%–45% (depending on the size of the silica-shelled 
quantum dots, and measured in distilled water, Figure 5).48 
However, without PEGylation, these amino-functionalized 
nanoparticles possessed good colloidal stability in dis-
tilled water and low-salt buffer, but not in saline solution, 
phosphate-buffered saline, or body fluids. For example, 
if mice were inoculated intranasally with non-PEGylated 
Table 5 effect of silica-shelled cdse/Zns QDs (conjugated with 
Peg1100) on cell viability in vitro (% from control)
Cell  
line
10 nM  
QD
50 nM  
QD
100 nM  
QD
200 nM  
QD
500 nM   
QD
Jurkat 101 ± 9 99 ± 7 100 ± 7 103 ± 10 98 ± 7
K562 100 ± 5 102 ± 8 98 ± 5 96 ± 8 98 ± 7
A549 98 ± 4 101 ± 5 98 ± 7 98 ± 9 96 ± 10
heLa 102 ± 6 103 ± 4 99 ± 9 98 ± 5 96 ± 8
Notes: The cell suspension (5 × 105 cells/mL) was incubated with QDs for 24 hours 
in a humidified atmosphere, and cell viability was analyzed by flow cytometry. Cell 
viability in the absence of QDs was considered to be 100% (control). The data are 
means ± standard deviations from six independent experiments.
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silica-shelled quantum dots, we observed a lot of aggregates 
in the nasal mucosa (Figure 6). Therefore, PEGylation and 
stabilization were necessary before these nanoparticles could 
be applied for imaging in vivo and especially in the case of 
intravenous and intranasal administration. The PEGylated 
silica-shelled quantum dots possessed high colloidal stability 
and did not aggregate in high-salt physiological fluids (eg, 
100 mM phosphate-buffered saline and plasma).
PEG1100-grafted silica-shelled quantum dots injected 
intravenously into the rat and brain vasculature were visu-
alized using two-photon excited fluorescent microscopy 
(Figure 7). The images were obtained at λex = 810 nm and an 
emission filter of 525 ± 50 nm, with scanning in the horizon-
tal plane at a depth of 150 µm from the surface of the skull. 
The fluorescent contrast was constant during 30 minutes of 
scanning. The PEG1100-grafted silica-shelled quantum dots 
gave clear images even at high concentrations (2.5 nmol 
quantum dots/kg bodyweight, Figure 7). On the other 
hand, 0.2 pmol quantum dots/kg bodyweight was enough 
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Figure 8 Model structure of Pegylated multimodal silica-shelled quantum dots.48
Note: Reprinted with permission from Zhelev Z, Ohba H, Bakalova R. Single quantum dot-micelles coated with silica shell as potentially non-cytotoxic fluorescent cell 
tracers. J Am Chem Soc. 2006;128:6324–6325. copyright 2006 American chemical society.
Abbreviations: PEG, polyethylene glycol; DOTA, tetraazacyclododecanetetraacetic acid.
Table 6 spectral characteristics of Peg1100-grafted multimodal 
silica-shelled QDs
Spectral characteristic Value
QY in 10 mM PBs, ph 7.4 (%) 35–48
QY in 100 mM PBs, ph 7.4 (%) 32–45
Longitudinal relaxation time, T1 (msec) 293.4 ± 23.5
Transverse relaxation time, T2 (msec) 128.5 ± 5.3
Notes: T 1  and  T2  data  are  means  ±  standard  deviations  from  six  independent 
experiments. T1 and T2 data were calculated at a QD concentration of 500 nM. 
The magnetic resonance imaging measurements were performed in a 4.7 T magnet 
(General  Electric,  Fairfield,  CT)  interfaced  to  a  Bruker  Avance  console  (Bruker 
Medical GmbH, Germany). A 30 mm diameter Litz coil (Doty Scientific Inc, Columbia, 
sc)  was  used  for  measurement  of  the  samples.  The  sample  temperature  was 
maintained at room temperature (approximately 22–24oc). The measurements were 
performed in the following order: T1-weighted imaging using conventional spin echo 
sequence; multiecho spin echo imaging for T2 calculations; and inversion recovery 
spin echo imaging for T1 calculations. For calculation of fluorescence quantum yield, 
the spectrally integrated emission of particle dispersion in different aqueous solutions 
was compared with the integrated emission of an ethanol solution of rhodamine g 
(Fluka) of identical optical density (0.015) at an excitation wavelength of 365 nm.
Abbreviations:  QD,  quantum  dot;  Peg,  polyethylene  glycol;  PBs,  phosphate-
buffered saline; QY, quantum yield.
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Figure  9  (A)  Fluorescent  imaging  of  tumor  by  angiogenesis  in  the  anesthetized 
mouse injected intravenously with Peg1100-grafted multimodal QD655 (1.6 nmol/kg 
bodyweight, single dose). Dashed lines indicate liver area and tumor area (including 
angiogenic network). The images were obtained 15 minutes after injection using an IVIs® 
imaging system, with excitation at 450 ± 30 nm and emission at 650 nm (DsRed filter). 
The images were obtained on day 10 after inoculation (1 × 105 cells in 10 µL). (B) 
Fluorescence intensity in tumor area, liver area, and other parts of the body (background 
fluorescence)  after  intravenous  injection  of  PEG1100-grafted  multimodal  QD655 
(1.6 nmol/kg bodyweight, single dose). Data were calculated from the images in A.
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to visualize the large-sized and middle-sized blood vessels 
at a depth of 150 µm. Increasing the concentration of the 
quantum dot probe, it was possible to visualize the arteries 
and veins at a depth of 600–700 µm. These quantum dots did 
not affect blood pressure or heart rate, and did not provoke 
vasodilatation or vasoconstriction up to 60 minutes after 
injection (Table 4). The PEGylated silica-shelled quantum 
dots were noncytotoxic in concentrations up to 500 nM, as 
determined in cultured cells (Table 5).
The PEG1100-grafted silica-shelled quantum dots655 were 
conjugated with DOTA/Gd3+, and the probe was applied for 
multimodal imaging of cancer in mice. This is a classical 
scheme for the multimodal quantum dot probes developed 
by other researchers (Figure 8).1,4
The fluorescent and magnetic resonance imaging char-
acteristics of our multimodal quantum dots are shown in 
Table 6. The fluorescent quantum yield was about 40% in 
high-salt buffer. The longitudinal and transverse relaxation 
times (T1 and T2) were about 290 msec and 120 msec, 
respectively.
The fluorescent images in Figure 9A show that the mul-
timodal silica-shelled quantum dots visualized the tumor 
by angiogenesis. The experimental tumor was developed 
within 10 days after inoculation of Colon32 cells in the left 
and right hind paws of mice. Fluorescence intensity in the 
tumor area was approximately three times higher than that in 
the surrounding tissues (Figure 9B). Maximum fluorescence 
intensity was detected in the liver area. It seems that these 
nanoparticles accumulated predominantly in the liver area 
within 90 minutes of their injection into the tail vein. Other 
authors have also reported that polymer-coated quantum 
dots accumulate predominantly in the liver, partially in the 
spleen, lung, and kidney, and are almost never observed in 
the heart and brain.49
The paramagnetic characteristics of the quantum dot 
probe also enabled visualization of tumors using magnetic 
resonance imaging (Figure 10). The short longitudinal relax-
ation time (T1) of gadolinium in the silica spheres allowed 
visualization of the tumor on the third day after inoculation, 
when tumor size was about 2 mm in diameter and the angio-
genic network was not well developed.
Conclusion
The data presented here show that the type and structure of 
organic/bioorganic shells of quantum dots are crucial for their 
colloidal stability and solubility in physiological fluids, and 
their biocompatibility and cytotoxicity. All these parameters 
have to be identified and controlled before application of 
organic-coated quantum dots for in vivo imaging. CdSe/
ZnS quantum dots, coated with non-crosslinked PAMAM 
dendrimers and amino-functionalized, are cytotoxic and 
nonbiocompatible. These quantum dots have side effects after 
intravenous administration in healthy animals, ie, decreased 
blood pressure and heart rate, as well as vasodilatation. 
Presumably this is as a result of instability of the dendrimer 
coat in the bloodstream and release of free monomers, induc-
ing cytotoxic mechanisms in the organism. These quantum 
dots are not appropriate for in vivo imaging of vasculature 
structure, because the nanoparticles seem to penetrate the 
vessels, affecting the quality of the images.
CdSe/ZnS quantum dots encapsulated in crosslinked car-
boxyl dendrimers have low cytotoxicity and comparatively 
good biocompatibility in concentrations up to 0.3 nmol/kg 
bodyweight. This quantum dot probe is appropriate for in 
vivo imaging. PEGylation is not required to increase the half-
life of dendrimer-coated quantum dots in the bloodstream.
Tumor
2 mm
Tumor
Angiogenic blood
vessels
Angiogenic blood
vessels
A Three days after inoculation (tumor diameter ~2 mm)
Before injection After injection
Before injection After injection
B Ten days after inoculation (tumor diameter ~6 mm)
2 mm
Figure 10 T1-weighted magnetic resonance images of colon cancer in the anesthetized 
mouse injected intravenously with Peg1100-grafted multimodal QD655 embedded 
with gadolinium (1 µmol/kg bodyweight, single dose). Dashed lines indicate tumor 
area (including angiogenic vasculature). The images were obtained immediately after 
injection, using 7.0 Tesla magnetic resonance imaging. Imaging parameters: spin echo 
sequence with fat suppression preparation pulse; repetition time 400 msec; echo 
time 9.574 msec; field of view 32 × 32 mm; matrix size 256 × 256; slice thickness 
1.0 mm; number of averages 4.
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However, PEGylation is an indispensable step in devel-
opment of quantum dot probes for in vivo imaging, based 
on silica-shelled quantum dots. Non-PEGylated and amino-
functionalized silica-shelled quantum dots have low colloidal 
stability in high-salt physiological fluids, which is accompa-
nied with rapid aggregation. The aggregates could induce 
activation of macrophages and a nonspecific immune response 
in vivo. The conjugation of silica-shelled quantum dots with 
PEG1100 increases their half-life in the circulation without 
significant enhancement of their size. PEG1100-grafted silica-
shelled quantum dots are appropriate for visualization of blood 
vasculature and circulation in vivo, using two-photon excited 
fluorescent microscopy. In concentrations up to 2.5 nmol/kg 
bodyweight injected intravenously, these quantum dots do not 
affect physiological variables, eg, blood pressure, heart rate, 
and blood vessel diameter. Using these quantum dots, it was 
possible to visualize capillaries, which makes them appropriate 
for investigation of mediators of vasoconstriction, vasodilata-
tion, and brain circulation in intact animals in vivo.
It should be noted that our results are related to use of quan-
tum dots for structural fluorescent imaging of blood vessels and 
tumors. Quantum dot probes with sensing properties also have 
potential for functional imaging diagnostics in vivo.50
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Figure S1 Experimental scheme of imaging of two-photon excited fluorescence in rats.
Abbreviation: QD, quantum dot.
Table S1 Physiological characteristics of rats before and after intravenous injection of polyamidoamine c12 dendrimer 0.1 nmol/kg 
bodyweight
Parameters Before injection About 20 minutes after injection P value
Mean arterial blood pressure (mmhg) 114.0 ± 5.5 68.3 ± 8.5 0.01
heart rate (beats per minute) 392 ± 24 317 ± 18 0.05
Mean diameter of detected arteries (µm) 29 ± 7 39 ± 11 (vasodilatation) 0.05
Mean diameter of detected veins (µm) 42 ± 21 47 ± 14 (vasodilatation) 0.05
Notes: Data are means ± standard deviations from five independent experiments. The experimental conditions are the same as in Table 1.
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Table S2 effect of PAMAM c12 dendrimers on cell viability in vitro (% from control)
Cell line 50 nM dendrimer 100 nM dendrimer 500 nM dendrimer
Jurkat 65 ± 5 37 ± 4 8 ± 4
K562 57 ± 9 31 ± 5 3 ± 1
A549 68 ± 9 40 ± 8 5 ± 1
heLa 70 ± 8 42 ± 4 12 ± 4
Notes: The cell suspension (5 × 105 cells/mL) was incubated with dendrimers over 24 hours in a humidified atmosphere, and cell viability was analyzed by flow cytometry. 
cell viability in the absence of dendrimer was considered 100% (control). The data are means ± standards deviation from six independent experiments.International Journal of Nanomedicine
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Table S3 Effect of water-soluble amino-functionalized CdSe/ZnS QD485 without additional organic shell on cell viability in vitro (% from 
control)
Cell line 10 nM QD 50 nM QD 100 nM QD 200 nM QD 500 nM QD
Jurkat 104 ± 5 98 ± 8 100 ± 2 97 ± 6 96 ± 8
K562 100 ± 3 101 ± 5 103 ± 4 97 ± 5 95 ± 5
A549 100 ± 6 103 ± 5 99 ± 8 100 ± 4 97 ± 4
heLa 102 ± 4 98 ± 7 97 ± 6 98 ± 5 94 ± 9
Notes: The cell suspension (5 × 105 cells/mL) was incubated with QDs within 24 hours at humidified atmosphere, and cell viability was analyzed by flow cytometry. The cell 
viability in absence of QD was considered 100% (control). Data are means ± standard deviations from six independent experiments.
Abbreviation: QD, quantum dot.